Use of a ferroptosis-related gene signature to construct diagnostic and prognostic models for assessing immune infiltration in metabolic dysfunction-associated fatty liver disease

被引:2
|
作者
Lian, Xin [1 ]
Tang, Xulei [1 ]
机构
[1] Lanzhou Univ, Clin Med Coll 1, Lanzhou, Gansu, Peoples R China
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2023年 / 11卷
关键词
metabolic dysfunction-associated fatty liver disease; ferroptosis; immune infiltration; bioinformatics; differentially expressed genes; ferroptosis-related genes; EXPRESSION; DATABASE; IRON; STEATOHEPATITIS; ENCYCLOPEDIA; NETWORKS; TOOL; GEO;
D O I
10.3389/fcell.2023.1199846
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Introduction: Metabolic dysfunction-associated fatty liver disease (MAFLD), a serious health problem worldwide, can involve ferroptosis. This study aimed to comprehensively analyze the ferroptosis-related genes associated with MAFLD.Methods: Ferroptosis-related differentially expressed genes (FRDEGs) were identified in patients with MAFLD and healthy individuals. Gene ontology functional enrichment analysis, Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis, and gene set enrichment analysis (GSEA) were used to analyze the relevant action pathways of the FRDEGs. The Encyclopedia of RNA Interactomes, CHIPBase, and comparative toxicogenomics databases were used to build mRNA-miRNA, mRNA-transcription factor (TF), and mRNA-drug interaction networks, respectively. A diagnostic model was constructed and bioinformatics analysis methods, such as least absolute shrinkage and selection operator regression analysis, Cox regression analysis, nomogram-based analysis, consensus clustering analysis, and single-sample GSEA, were used to systematically investigate the prognostic values and immunologic characteristics.Results: A total of 13 FRDEGs were obtained and eight were used to construct a diagnostic model and perform a prognostic analysis. Hub genes were also used to construct mRNA-miRNA and mRNA-TF interaction networks and potential drug or molecular compounds. Two MAFLD subtypes were identified: cluster2, which represents an "immunoactive" type, and cluster1, which represents an "immunosuppressive" type; a significant correlation was observed between the immune cell contents and the expression of three FRDEGs (NR4A1, FADS2, and SCD).Conclusion: A ferroptosis-related gene signature was constructed to diagnose MAFLD-associated steatohepatitis, predict the prognosis of MAFLD patients, and analyze the immunologic characteristics of MAFLD. Our findings may provide insights into developing innovative MAFLD treatment techniques.
引用
收藏
页数:24
相关论文
共 21 条
  • [1] Immune infiltration analysis based on pyroptosis-related gene in metabolic dysfunction-associated fatty liver disease
    Lian, Xin
    Tang, Xulei
    HELIYON, 2024, 10 (15)
  • [2] Novel insights into the pathogenesis of thyroid eye disease through ferroptosis-related gene signature and immune infiltration analysis
    Ye, Yunyan
    Dai, Lei
    Mugaanyi, Joseph
    Fu, Weina
    Hu, Feng
    AGING-US, 2024, 16 (07): : 6008 - 6034
  • [3] Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?
    Feng, Gong
    Byrne, Christopher D.
    Targher, Giovanni
    Wang, Fudi
    Zheng, Ming-Hua
    LIVER INTERNATIONAL, 2022, 42 (07) : 1496 - 1502
  • [4] Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs
    Zhu, Baoqiang
    Wei, Yuankui
    Zhang, Mingming
    Yang, Shiyu
    Tong, Rongsheng
    Li, Wenyuan
    Long, Enwu
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [5] Bioinformatics analysis of ferroptosis-related genes and immune cell infiltration in non-alcoholic fatty liver disease
    Zhang, Huan
    Axinbai, Malina
    Zhao, Yuqing
    Wei, Jiaoyang
    Qu, Tongshuo
    Kong, Jingmin
    He, Yongqiang
    Zhang, Liping
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [6] Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation
    Yang, Mengmeng
    Xia, Longqing
    Song, Jia
    Hu, Huiqing
    Zang, Nan
    Yang, Jingwen
    Zou, Ying
    Wang, Liming
    Zheng, Xiaoyue
    He, Qin
    Liu, Jidong
    Liu, Fuqiang
    Liang, Kai
    Sun, Lei
    Chen, Li
    LIPIDS IN HEALTH AND DISEASE, 2023, 22 (01)
  • [7] Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation
    Mengmeng Yang
    Longqing Xia
    Jia Song
    Huiqing Hu
    Nan Zang
    Jingwen Yang
    Ying Zou
    Liming Wang
    Xiaoyue Zheng
    Qin He
    Jidong Liu
    Fuqiang Liu
    Kai Liang
    Lei Sun
    Li Chen
    Lipids in Health and Disease, 22
  • [8] Bioinformatics analysis of ferroptosis-related genes and immune cell infiltration in non-alcoholic fatty liver disease
    Huan Zhang
    Malina Axinbai
    Yuqing Zhao
    Jiaoyang Wei
    Tongshuo Qu
    Jingmin Kong
    Yongqiang He
    Liping Zhang
    European Journal of Medical Research, 28
  • [9] Metformin suppresses metabolic dysfunction-associated fatty liver disease by ferroptosis and apoptosis via activation of oxidative stress
    Li, Zhiyu
    Cui, Chao
    Xu, Liang
    Ding, Mingfeng
    Wang, Yinghui
    FREE RADICAL RESEARCH, 2024, 58 (11) : 686 - 701
  • [10] Intermittent hypoxia exacerbates metabolic dysfunction-associated fatty liver disease by aggravating hepatic copper deficiency-induced ferroptosis
    Wang, Ruhua
    Lv, Yuerong
    Ni, Ziyan
    Feng, Wei
    Fan, Pei
    Wang, Yan
    Lin, Yiguang
    Chen, Xueqing
    FASEB JOURNAL, 2024, 38 (13)